P3 Health Net Worth
P3 Health Net Worth Breakdown | PIIIW |
P3 Health Net Worth Analysis
P3 Health's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including P3 Health's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of P3 Health's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform P3 Health's net worth analysis. One common approach is to calculate P3 Health's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares P3 Health's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing P3 Health's net worth. This approach calculates the present value of P3 Health's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of P3 Health's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate P3 Health's net worth. This involves comparing P3 Health's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into P3 Health's net worth relative to its peers.
Enterprise Value |
|
To determine if P3 Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding P3 Health's net worth research are outlined below:
| P3 Health Partners generated a negative expected return over the last 90 days | |
| P3 Health Partners has high historical volatility and very poor performance | |
| P3 Health Partners has some characteristics of a very speculative penny stock | |
| P3 Health Partners has high likelihood to experience some financial distress in the next 2 years | |
| P3 Health Partners has accumulated 121.94 M in total debt. P3 Health Partners has a current ratio of 0.44, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about P3 Health's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the revenue of 1.27 B. Net Loss for the year was (57.77 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| P3 Health Partners has accumulated about 4.34 M in cash with (76.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.1, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| P3 Health Partners has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Some P3 Health Partners Inc. Analysts Just Made A Major Cut To Next Years Estimates - Simply Wall St |
Project P3 Health's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.30) | (0.31) | |
| Return On Capital Employed | (0.30) | (0.31) | |
| Return On Assets | (0.07) | (0.07) | |
| Return On Equity | (0.41) | (0.43) |
When accessing P3 Health's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures P3 Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of P3 Health's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in P3 Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of P3 Health Partners. Check P3 Health's Beneish M Score to see the likelihood of P3 Health's management manipulating its earnings.
Evaluate P3 Health's management efficiency
The company has return on total asset (ROA) of (0.1202) % which means that it has lost $0.1202 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4125) %, meaning that it generated substantial loss on money invested by shareholders. P3 Health's management efficiency ratios could be used to measure how well P3 Health manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.31 in 2024. Return On Capital Employed is likely to drop to -0.31 in 2024. At this time, P3 Health's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to climb to about 806.1 M in 2024, whereas Intangible Assets are likely to drop slightly above 601 M in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 4.57 | 4.34 | |
| Tangible Book Value Per Share | (2.46) | (2.58) | |
| Enterprise Value Over EBITDA | (2.59) | (2.72) | |
| Price Book Value Ratio | 0.87 | 0.83 | |
| Enterprise Value Multiple | (2.59) | (2.72) | |
| Price Fair Value | 0.87 | 0.83 | |
| Enterprise Value | 278.5 M | 398.5 M |
The operational strategies employed by P3 Health management play a crucial role in its market positioning. Assessing these strategies alongside financial data helps us evaluate the stock's investment potential.
Revenue 1.4 B | Quarterly Revenue Growth 0.152 | Revenue Per Share 11.552 | Return On Equity (0.41) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific P3 Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on P3 Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases P3 Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Chicago Pacific Founders Ugp Iii, Llc over a month ago Acquisition by Chicago Pacific Founders Ugp Iii, Llc of 90000 shares of P3 Health at 2.628 subject to Rule 16b-3 | ||
Chicago Pacific Founders Ugp Iii, Llc over three months ago Acquisition by Chicago Pacific Founders Ugp Iii, Llc of 90000 shares of P3 Health at 3.009 subject to Rule 16b-3 | ||
Chicago Pacific Founders Ugp Iii, Llc over three months ago Acquisition by Chicago Pacific Founders Ugp Iii, Llc of 90000 shares of P3 Health at 3.2417 subject to Rule 16b-3 | ||
Chicago Pacific Founders Ugp Iii, Llc over six months ago Acquisition by Chicago Pacific Founders Ugp Iii, Llc of 90000 shares of P3 Health at 2.628 subject to Rule 16b-3 | ||
Bacchus Amir over six months ago Acquisition by Bacchus Amir of 3758130 shares of P3 Health at 375.81 subject to Rule 16b-3 | ||
Hudson Vegas Investment Spv, Llc over six months ago Disposition of 43974331 shares by Hudson Vegas Investment Spv, Llc of P3 Health subject to Rule 16b-3 |
P3 Health Earnings per Share Projection vs Actual
P3 Health Corporate Management
| Unmesh Srivastava | Chief Officer | Profile | |
| BSN CRNI | Chief Staff | Profile | |
| Leslie Fisher | General Affairs | Profile | |
| Kassi APR | Culture Communications | Profile | |
| Todd MHA | Chief Officer | Profile | |
| Eric Atkins | Chief Officer | Profile |
Additional Tools for PIIIW Stock Analysis
When running P3 Health's price analysis, check to measure P3 Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy P3 Health is operating at the current time. Most of P3 Health's value examination focuses on studying past and present price action to predict the probability of P3 Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move P3 Health's price. Additionally, you may evaluate how the addition of P3 Health to your portfolios can decrease your overall portfolio volatility.